Iver Nordentoft

7.5k total citations
57 papers, 2.9k citations indexed

About

Iver Nordentoft is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Iver Nordentoft has authored 57 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Surgery, 25 papers in Molecular Biology and 24 papers in Cancer Research. Recurrent topics in Iver Nordentoft's work include Bladder and Urothelial Cancer Treatments (29 papers), Cancer Genomics and Diagnostics (19 papers) and Epigenetics and DNA Methylation (13 papers). Iver Nordentoft is often cited by papers focused on Bladder and Urothelial Cancer Treatments (29 papers), Cancer Genomics and Diagnostics (19 papers) and Epigenetics and DNA Methylation (13 papers). Iver Nordentoft collaborates with scholars based in Denmark, United States and Germany. Iver Nordentoft's co-authors include Lars Dyrskjøt, Torben F. Ørntoft, Søren Vang, Karin Birkenkamp‐Demtröder, Jørgen Bjerggaard Jensen, Philippe Lamy, Jakob Skou Pedersen, Mads Agerbæk, Emil Christensen and S. Høyer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Iver Nordentoft

55 papers receiving 2.9k citations

Peers

Iver Nordentoft
Ishtiaq Rehman United Kingdom
Mariana Brait United States
Woonbok Chung United States
A K Virmani United States
Nicola Valeri United Kingdom
Keun Hur South Korea
Ishtiaq Rehman United Kingdom
Iver Nordentoft
Citations per year, relative to Iver Nordentoft Iver Nordentoft (= 1×) peers Ishtiaq Rehman

Countries citing papers authored by Iver Nordentoft

Since Specialization
Citations

This map shows the geographic impact of Iver Nordentoft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iver Nordentoft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iver Nordentoft more than expected).

Fields of papers citing papers by Iver Nordentoft

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iver Nordentoft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iver Nordentoft. The network helps show where Iver Nordentoft may publish in the future.

Co-authorship network of co-authors of Iver Nordentoft

This figure shows the co-authorship network connecting the top 25 collaborators of Iver Nordentoft. A scholar is included among the top collaborators of Iver Nordentoft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iver Nordentoft. Iver Nordentoft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juul, Randi Istrup, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2025). Low T cell diversity associates with poor outcome in bladder cancer: A comprehensive longitudinal analysis of the T cell receptor repertoire. Cell Reports Medicine. 6(5). 102101–102101. 1 indexed citations
2.
Jensen, Jørgen Bjerggaard, Karin Birkenkamp‐Demtröder, Iver Nordentoft, et al.. (2024). 1960O Identification of bladder cancer patients that could benefit from early post-cystectomy immunotherapy based on serial circulating tumour DNA (ctDNA) testing: Preliminary results from the TOMBOLA trial. Annals of Oncology. 35. S1133–S1133. 15 indexed citations
3.
Nordentoft, Iver, Sia V. Lindskrog, Philippe Lamy, et al.. (2023). Improved protocol for single-nucleus RNA-sequencing of frozen human bladder tumor biopsies. Nucleus. 14(1). 2186686–2186686. 2 indexed citations
4.
Christensen, Emil, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2023). Cell-Free Urine and Plasma DNA Mutational Analysis Predicts Neoadjuvant Chemotherapy Response and Outcome in Patients with Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 29(8). 1582–1591. 36 indexed citations
5.
Lindskrog, Sia V., Karin Birkenkamp‐Demtröder, Iver Nordentoft, et al.. (2023). Circulating Tumor DNA Analysis in Advanced Urothelial Carcinoma: Insights from Biological Analysis and Extended Clinical Follow-up. Clinical Cancer Research. 29(23). 4797–4807. 26 indexed citations
6.
Strandgaard, Trine, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2023). Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer. European Urology. 85(1). 82–92. 21 indexed citations
7.
Strandgaard, Trine, Sia V. Lindskrog, Iver Nordentoft, et al.. (2022). Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer. European Urology. 82(6). 646–656. 39 indexed citations
8.
Lamy, Philippe, Sia V. Lindskrog, Emil Christensen, et al.. (2021). SPTAN1, APC, and FGFR3 Mutation Status and APOBEC Mutation Signatures are Predictive of Mitomycin C Response in Non-muscle-invasive Bladder Cancer. European Urology Open Science. 34. 59–67.
9.
Strandgaard, Trine, Iver Nordentoft, Philippe Lamy, et al.. (2020). Mutational Analysis of Field Cancerization in Bladder Cancer. Bladder Cancer. 6(3). 253–264. 10 indexed citations
10.
Sjödahl, Gottfrid, Pontus Eriksson, Kristina Lövgren, et al.. (2018). Discordant molecular subtype classification in the basal-squamous subtype of bladder tumors and matched lymph-node metastases. Modern Pathology. 31(12). 1869–1881. 40 indexed citations
11.
Schøler, Lone V., Thomas Reinert, Mai‐Britt W. Ørntoft, et al.. (2017). Clinical Implications of Monitoring Circulating Tumor DNA in Patients with Colorectal Cancer. Clinical Cancer Research. 23(18). 5437–5445. 230 indexed citations
12.
Seitz, Anna Katharina, Lise Lotte Christensen, Emil Christensen, et al.. (2017). Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer. Scientific Reports. 7(1). 395–395. 100 indexed citations
13.
Christensen, Emil, Karin Birkenkamp‐Demtröder, Iver Nordentoft, et al.. (2017). Liquid Biopsy Analysis of FGFR3 and PIK3CA Hotspot Mutations for Disease Surveillance in Bladder Cancer. European Urology. 71(6). 961–969. 148 indexed citations
14.
Lamy, Philippe, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2016). Paired Exome Analysis Reveals Clonal Evolution and Potential Therapeutic Targets in Urothelial Carcinoma. Cancer Research. 76(19). 5894–5906. 68 indexed citations
15.
Trolle, Christian, Morten Muhlig Nielsen, Anne Skakkebæk, et al.. (2016). Widespread DNA hypomethylation and differential gene expression in Turner syndrome. Scientific Reports. 6(1). 34220–34220. 93 indexed citations
16.
Thomsen, Mathilde Borg Houlberg, Iver Nordentoft, Philippe Lamy, et al.. (2016). Spatial and temporal clonal evolution during development of metastatic urothelial carcinoma. Molecular Oncology. 10(9). 1450–1460. 36 indexed citations
17.
Birkenkamp‐Demtröder, Karin, Iver Nordentoft, Emil Christensen, et al.. (2016). Genomic Alterations in Liquid Biopsies from Patients with Bladder Cancer. European Urology. 70(1). 75–82. 168 indexed citations
18.
Dalgaard, Marlene, Rachita Yadav, K Rasmussen, et al.. (2014). Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients. Leukemia. 29(2). 297–303. 14 indexed citations
19.
Nielsen, Morten Muhlig, Disa Tehler, Søren Vang, et al.. (2013). Identification of expressed and conserved human noncoding RNAs. RNA. 20(2). 236–251. 41 indexed citations
20.
Nordentoft, Iver, Lars Dyrskjøt, Julie Støve Bødker, et al.. (2011). Increased expression of transcription factor TFAP2α correlates with chemosensitivity in advanced bladder cancer. BMC Cancer. 11(1). 135–135. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026